John Kokkinos

1.5k total citations
17 papers, 985 citations indexed

About

John Kokkinos is a scholar working on Complementary and alternative medicine, Cardiology and Cardiovascular Medicine and Molecular Biology. According to data from OpenAlex, John Kokkinos has authored 17 papers receiving a total of 985 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Complementary and alternative medicine, 7 papers in Cardiology and Cardiovascular Medicine and 5 papers in Molecular Biology. Recurrent topics in John Kokkinos's work include Cardiovascular and exercise physiology (8 papers), Blood Pressure and Hypertension Studies (6 papers) and Physical Activity and Health (5 papers). John Kokkinos is often cited by papers focused on Cardiovascular and exercise physiology (8 papers), Blood Pressure and Hypertension Studies (6 papers) and Physical Activity and Health (5 papers). John Kokkinos collaborates with scholars based in United States, Australia and Greece. John Kokkinos's co-authors include Peter Kokkinos, Vasilios Papademetriou, Jonathan Myers, Andreas Pittaras, Pamela Karasik, Michael D. Greenberg, Charles Faselis, Michael Doumas, Ross D. Fletcher and Steven Singh and has published in prestigious journals such as Circulation, PLoS ONE and Biomaterials.

In The Last Decade

John Kokkinos

17 papers receiving 937 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
John Kokkinos United States 14 471 413 365 143 107 17 985
Tormod S. Nilsen Norway 15 380 0.8× 257 0.6× 290 0.8× 106 0.7× 46 0.4× 31 1.2k
Christopher J. Womack United States 18 139 0.3× 99 0.2× 196 0.5× 156 1.1× 164 1.5× 47 956
Melissa J. Pearson Australia 16 373 0.8× 220 0.5× 89 0.2× 39 0.3× 20 0.2× 27 730
J. S. Kennedy United Kingdom 18 742 1.6× 557 1.3× 153 0.4× 175 1.2× 32 0.3× 32 1.3k
Rosa Lucci Italy 16 448 1.0× 199 0.5× 64 0.2× 70 0.5× 90 0.8× 21 799
M. Cerqueira United States 10 221 0.5× 133 0.3× 188 0.5× 64 0.4× 40 0.4× 17 674
Sonia H. Torres Venezuela 14 108 0.2× 120 0.3× 191 0.5× 126 0.9× 28 0.3× 40 587
Laura Salvi Italy 13 92 0.2× 63 0.2× 159 0.4× 110 0.8× 34 0.3× 25 735
Luc Bruyndonckx Belgium 12 186 0.4× 47 0.1× 105 0.3× 109 0.8× 72 0.7× 24 477
Yasutomi Katayama Japan 12 99 0.2× 41 0.1× 207 0.6× 64 0.4× 64 0.6× 31 472

Countries citing papers authored by John Kokkinos

Since Specialization
Citations

This map shows the geographic impact of John Kokkinos's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John Kokkinos with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John Kokkinos more than expected).

Fields of papers citing papers by John Kokkinos

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John Kokkinos. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John Kokkinos. The network helps show where John Kokkinos may publish in the future.

Co-authorship network of co-authors of John Kokkinos

This figure shows the co-authorship network connecting the top 25 collaborators of John Kokkinos. A scholar is included among the top collaborators of John Kokkinos based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John Kokkinos. John Kokkinos is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Kenwright, Diane, Kathryn Hally, Margaret J. Currie, et al.. (2024). Development of a long term, ex vivo, patient-derived explant model of endometrial cancer. PLoS ONE. 19(4). e0301413–e0301413. 1 indexed citations
2.
Kokkinos, John, George Sharbeen, Koroush S. Haghighi, et al.. (2021). Ex vivo culture of intact human patient derived pancreatic tumour tissue. Scientific Reports. 11(1). 1944–1944. 46 indexed citations
3.
Kokkinos, John, George Sharbeen, Joshua A. McCarroll, et al.. (2021). Does the Microenvironment Hold the Hidden Key for Functional Precision Medicine in Pancreatic Cancer?. Cancers. 13(10). 2427–2427. 6 indexed citations
4.
Kokkinos, John, Rosa Mistica C. Ignacio, George Sharbeen, et al.. (2020). Targeting the undruggable in pancreatic cancer using nano-based gene silencing drugs. Biomaterials. 240. 119742–119742. 51 indexed citations
5.
Ong, Kwok Leung, Ben J. Wu, Robyn L. McClelland, et al.. (2019). Relationship of fibroblast growth factor 21 with subclinical atherosclerosis and cardiovascular events: Multi-Ethnic Study of Atherosclerosis. Atherosclerosis. 287. 46–53. 17 indexed citations
6.
Ong, Kwok Leung, Robyn L. McClelland, Matthew Allison, et al.. (2018). Association of elevated circulating fibroblast growth factor 21 levels with prevalent and incident metabolic syndrome: The Multi-Ethnic Study of Atherosclerosis. Atherosclerosis. 281. 200–206. 19 indexed citations
7.
Kokkinos, John, et al.. (2016). The role of fibroblast growth factor 21 in atherosclerosis. Atherosclerosis. 257. 259–265. 58 indexed citations
8.
Kokkinos, Peter, Charles Faselis, Jonathan Myers, et al.. (2014). Cardiorespiratory Fitness and the Paradoxical BMI-Mortality Risk Association in Male Veterans. Mayo Clinic Proceedings. 89(6). 754–762. 26 indexed citations
9.
Kokkinos, Peter, Charles Faselis, J. Myers, et al.. (2014). Statin Therapy, Fitness, and Mortality Risk in Middle-Aged Hypertensive Male Veterans. American Journal of Hypertension. 27(3). 422–430. 19 indexed citations
10.
Faselis, Charles, Michael Doumas, Jonathan Myers, et al.. (2013). Heart Rate at Rest, Exercise Capacity, and Mortality Risk in Veterans. The American Journal of Cardiology. 112(10). 1605–1609. 18 indexed citations
11.
Faselis, Charles, Michael Doumas, John Kokkinos, et al.. (2012). Exercise Capacity and Progression From Prehypertension to Hypertension. Hypertension. 60(2). 333–338. 87 indexed citations
12.
Kokkinos, Peter, Jonathan Myers, Michael Doumas, et al.. (2011). Heart rate recovery, exercise capacity, and mortality risk in male veterans. European Journal of Preventive Cardiology. 19(2). 177–184. 27 indexed citations
13.
Kokkinos, Peter, Jonathan Myers, Charles Faselis, et al.. (2010). Exercise Capacity and Mortality in Older Men. Circulation. 122(8). 790–797. 241 indexed citations
14.
Kokkinos, Peter, J. Myers, Michael Doumas, et al.. (2009). Exercise Capacity and All-Cause Mortality in Prehypertensive Men. American Journal of Hypertension. 22(7). 735–741. 36 indexed citations
15.
Kokkinos, Peter, Michael Doumas, Jonathan Myers, et al.. (2009). A graded association of exercise capacity and all-cause mortality in males with high-normal blood pressure. Blood Pressure. 18(5). 261–267. 28 indexed citations
16.
Kokkinos, Peter, Michael Doumas, Jonathan Myers, et al.. (2009). A graded association of exercise capacity and all-cause mortality in males with high-normal blood pressure. Blood Pressure. 18(5). 261–267. 2 indexed citations
17.
Kokkinos, Peter, Jonathan Myers, John Kokkinos, et al.. (2008). Exercise Capacity and Mortality in Black and White Men. Circulation. 117(5). 614–622. 303 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026